Chronic MDMA (ecstasy) use, cognition and mood

Abstract

Rationale

It has been suggested that 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) causes damage to the serotonergic system, and that this damage results in cognitive and mood impairments.

Objectives

To examine the effect of chronic MDMA usage on a wide battery of cognitive tests and psychological abilities and processes.

Methods

In the present study, the performance of 17 participants with a history of MDMA use was compared to the performance of 15 control subjects on a battery of neuropsychological tests. This battery included tests for depression, immediate word recall, delayed recall, attention and working memory.

Results

Results indicated that the MDMA group had significantly higher scores for depression than the control group, and displayed poorer delayed recall and verbal learning than controls after accounting statistically for the effects of cannabis and depression.

Conclusions

These results suggest that MDMA users exhibit difficulties in coding information into long-term memory, display impaired verbal learning, are more easily distracted, and are less efficient at focusing attention on complex tasks.

This is a preview of subscription content, access via your institution.

References

  1. Altman HJ, Nordy DA, Ogren SO (1984) Role of serotonin in memory: facilitation by alaproclate and zimeldine. Psychopharmacology 84:496–502

    CAS  PubMed  Google Scholar 

  2. Baddeley A, Emslie H, Nimmo-Smith I (1992) Speed and capacity of language processing test manual. UK Thames Valley Test Company, Bury St Edmunds, UK

  3. Beck A, Steer R, Ball R, Ranieri W (1996) Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Person Assess 67:588–597

    CAS  Google Scholar 

  4. Bolla KI, McCann UD, Ricaurte GA (1998) Memory impairment in abstinent MDMA (“MDMA”) users. Neurology 51:1532–1537

    CAS  PubMed  Google Scholar 

  5. Cole J, Sumnall H, Grob C (2002) Sorted: ecstasy facts and fiction. Psychologist 15:464–467

    Google Scholar 

  6. Croft RJ (2002) “Danger” remains best message. Psychologist 15:470–471

    Google Scholar 

  7. Croft RJ, Klugman A, Baldeweg T, Gruzelier JH (2001a) Electrophysiological evidence of serotonergic impairment in long-term MDMA (“ecstasy”) users. Am J Psychiatry 158:1687–1692

    CAS  PubMed  Google Scholar 

  8. Croft RJ, Mackay A, Mills A, Gruzelier JH (2001b) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153:373–379

    Article  CAS  PubMed  Google Scholar 

  9. Curran HV, Travill RA (1997) Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA): weekend “high” followed by mid-week low. Addiction 92:821–831

    Article  CAS  PubMed  Google Scholar 

  10. Downing J (1986) The psychological physiological effects of MDMA on normal volunteers. J Psychoact Drugs 18:335–339

    CAS  Google Scholar 

  11. Giovagnoli AR, Del Pesce M, Mascheroni S, Simonceli M, Laiacona M, Captitani E (1996) Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci 17:305–309

    CAS  PubMed  Google Scholar 

  12. Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert H, Fimm B, Sass H (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68:719–725

    CAS  PubMed  Google Scholar 

  13. Grob CS (2000) Deconstructing MDMA: the politics of MDMA research. Addict Res 8:549–588

    Google Scholar 

  14. Harold K (2001) The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. Can Med Assoc J 165:917–928

    CAS  Google Scholar 

  15. Kish SJ (2002) How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacol Biochem Behav 71:845–855

    Google Scholar 

  16. Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR (1992) Chronic 3,4-methylenedioxymetamphetamine (MDMA) use: effects on mood and neuropsychological function? Am J Drug Alcohol Abuse 18:331–341

    CAS  PubMed  Google Scholar 

  17. Lezak MD (1995) Neuropsychological assessment, 3rd edn. Oxford University Press, New York

  18. McEntee WJ, Crook TH (1991) Serotonin, memory, and the aging brain. Psychopharmacology 103:143–149

    CAS  PubMed  Google Scholar 

  19. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomographic evidence of toxic effect of MDMA (“ecstasy”) on brain serotonin neurons in human beings. Lancet 352:1433–1437

    CAS  PubMed  Google Scholar 

  20. McCann UD, Mertl M, Eligulashvili V, Ricaurte GA (1999) Cognitive performance in (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study. Psychopharmacology 143:417–425

    CAS  PubMed  Google Scholar 

  21. McNair DM, Lorr M, Droppleman LF (1992) Manual for the Profile of Mood States. Educational and Industrial Testing Service, San Diego, Calif.

  22. Molliver ME, Berger UV, Mamounas LA, Molliver DC, O’Hearn E, Wilson MA (1990) Neurotoxicity of MDMA and related compounds: anatomic studies. Ann N Y Acad Sci 600:640–664

    Google Scholar 

  23. Morgan MJ (1999) Memory deficits associated with recreational use of “ecstasy” (MDMA). Psychopharmacology 141:30–36

    Article  CAS  PubMed  Google Scholar 

  24. Parrott AC (2002) Very real, very damaging. Psychologist 15:472–473

    Google Scholar 

  25. Parrott AC, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 139:261–268

    Article  CAS  PubMed  Google Scholar 

  26. Peroutka SJ, Newman H, Harris H (1988) Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1:273–277

    CAS  PubMed  Google Scholar 

  27. Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J (2001) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”). Arch Gen Psychiatry 58:901–906

    CAS  PubMed  Google Scholar 

  28. Rey A (1964) L’examen clinique psychologie. Presses Universitaires de France, Paris

  29. Ricaurte GA, Martello AL, Katz JL, Martello MB. (1992) Lasting effects of (±)3,4-methylenedioxymethamphetamine on central serotonergic neurons in non-human primates. J Pharmacol Exp Theory 261:616–622

    CAS  Google Scholar 

  30. Schear JM, Sato SD (1989) Effects of visual acuity and visual motor speed and dexterity on cognitive test performance. Arch Clin Neuropsychol 4:25–32

    Article  CAS  PubMed  Google Scholar 

  31. Schifano F (2000) Potential human neurotoxicity of MDMA (“ecstasy”): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies. Neuropsychobiology 42:25–33

    CAS  PubMed  Google Scholar 

  32. Semple DM, Ebmeier KP, Glabus MF, O’Carroll RE, Johnstone EC (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (“ecstasy”) users. Br J Psychiatry 175:63–69

    CAS  PubMed  Google Scholar 

  33. Solowij N, Hall W, Lee N (1992) Recreational MDMA use in Sydney: a profile of “ecstasy” users and their experiences with the drug. Br J Addict 87:1161–1172

    CAS  PubMed  Google Scholar 

  34. Steele T, McCann UD, Ricaurte GA (1994) 3,4-Methylendioxymethamphetamine (“ecstasy”): pharmacology and toxicology in animals and humans. Addiction 89:539–551

    CAS  PubMed  Google Scholar 

  35. Wechsler D (1981) WAIS-R manual. Psychological Corporation, New York

  36. Wood SJ, Proffitt T, Mahony K, Smith DJ, Buchanan JA, Brewer W, Stuart GW, Velakoulis D, McGorry PD, Pantelis C (2002) Visuospatial memory and learning in first-episode schizophreniform psychosis and established schizophrenia: a functional correlate of hippocampal pathology? Psychol Med 32:429–438

    Article  CAS  PubMed  Google Scholar 

  37. Young SN, Smith SE, Pihl RO, Ervin FR (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87:173–177

    CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to C. Stough.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

McCardle, K., Luebbers, S., Carter, J.D. et al. Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology 173, 434–439 (2004). https://doi.org/10.1007/s00213-004-1791-0

Download citation

Keywords

  • Ecstasy
  • Cognition
  • Mood
  • MDMA